Does anyone know what the function of defline starting with '+' in a fastq format file really is except providing some descriptive information? If it does not have any function in downstream analysis, does it mean that we can ignore this line (if we do not care the descriptive information)? I think people can save some space by minimizing the defline.
Unconfigured Ad
Collapse
X
-
-
It's a delimiter between the sequence and quality lines. Trust me if you've dealt with enough Fasta like formats over the years that people have mutilated in various text editors (or worse, word processors), you need something more definitive than a linebreak to tell the difference.
There is no requirement for them to match the metadata in the @ line.
Comment
-
That is a minority view. The FASTQ format such as it is requires the '+' line to match the '@' or be left blank. Many parsers will reject it otherwise.Originally posted by Bukowski View PostThere is no requirement for them to match the metadata in the @ line.
http://dx.doi.org/10.1093/nar/gkp1137
Comment
-
All the HiSeq data I get has no metadata in that line. Is that the default for HiSeqs? In which case it might be a majority viewOriginally posted by maubp View PostThat is a minority view. The FASTQ format such as it is requires the '+' line to match the '@' or be left blank. Many parsers will reject it otherwise.
http://dx.doi.org/10.1093/nar/gkp1137
Comment
-
Ah, that wasn't what I parsed from your comment, thanks for the clarification! And in fact it was my initial comment that was unclear, I should have stated that it could be left blank, not that they shouln' t match. My bad.Originally posted by maubp View PostLeaving the '+' line blank ought be the norm by now - the disk space saving alone is a compelling argument.
(If my earlier comment was unclear, I'm saying conflicting '@' and '+' lines is non-standard and a bad idea)
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
21 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
27 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Comment